Cancer · May 14, 2026
FDA Approves First BCL2 Inhibitor for Tough-to-Treat Mantle Cell Lymphoma
BeOne receives FDA approval for a new mantle cell lymphoma therapy, establishing an entirely new class of treatment options for pa...